The extracellular Ca 
Introduction
Changes in the concentration of intracellular calcium ([Ca 2+ ] i ) play a central role in a vast array of diverse cellular processes from proliferation, growth and development, to hormone secretion and neuronal transmission. These changes in [Ca 2+ ] i arise via the mobilisation of stored Ca 2+ from cytoplasmic pools, and/or Ca 2+ entry across the plasma membrane via various influx pathways. The concentration of systemic free ionised Ca 2+ is maintained within a narrow range (1·1-1·3 mM) by mechanisms involving parathyroid hormone (PTH)-secreting cells, and various other specialised tissues. Because of this, it is widely perceived that the concentration of Ca 2+ outside those cells not directly involved in systemic Ca 2+ homeostasis merely serves to sustain normal cellular function. As a result, most researchers culture cells in standard tissue culture media, which commonly contain a slightly supraphysiological Ca 2+ concentration (usually 1·8-2mM, as compared with an ambient in situ concentration of 1·1-1·3 mM). However, it is becoming increasingly apparent that local Ca 2+ concentrations at the cell surface of many cells vary markedly, and that these changes may influence cell physiology via a receptor-mediated mechanism. (Scherubi et al. 1991) , or non-selective cation channels (NSCC) (Silva et al. 1994) , depending on the cell type being investigated. Activation of the CaR is coupled to downstream signalling events through multiple G-protein-mediated cascades, and elevation in extracellular Ca 2+ also inhibits agonist-evoked cAMP accumulation (Fig. 1) . The net effect is reduced parathyroid hormone secretion, and the subsequent rectification of systemic normocalcaemia (extensively reviewed in Chattopadhyay et al. 1996 , Baum & Harris 1998 . It is interesting to consider that secretion from calcitonin-secreting C-cells of the thyroid is stimulated by elevated systemic Ca 2+ , but both PTH-secreting cells and C-cells reportedly express the same CaR (Garrett et al. 1995) . The clinical significance of CaR expression in PTH-secreting cells is highlighted by the marked pathophysiology observed in patients with altered receptor affinity for extracellular Ca 2+ (Pollak et al. 1994a , for review see Pearce & Thakker 1997 , Thakker 1998 . Variations in receptor affinity can arise from a single point mutation in the CaR, as seen in familial hypocalciuric hypercalcaemia (Pollak et al. 1994b , Chou et al. 1995 .
Extracellular

Other CaR agonists
Although Ca 2+ is the most relevant physiological ligand, other polyvalent cations and polycationic molecules, e.g. spermine, spermidine, neomycin and gadolinium, also activate the CaR (Brown et al. 1993 , Quinn et al. 1997 . Kifor & Brown 1988 , Chen et al. 1989 , Brown et al. 1993 , Nemeth 1995 These polycationic CaR agonists probably interact with the CaR electrostatically, screening charged amino acids on the extracellular domain of the receptor (Quinn et al. 1998) . Activation of the CaR, via these polyvalent ligands, may be subject to modification by conditions such as a change in ionic strength (Traynelis et al. 1993) . The capacity of the CaR to sense ionic strength (and therefore sodium concentration), and its presence in areas of the hypothalamus that mediate vasopressin secretion (Rogers et al. 1997) indicate that CaR has a role in transducing the effects of changes in ionic composition, with implications for the neural control of fluid balance (Washburn et al. 1999) .
CaR in gastrin-secreting G-cells
Although there are now extensive data on the role of the CaR in systemic Ca 2+ homeostasis, it has become increasingly apparent that CaR expression is not limited only to cells directly involved in the maintenance of normocalcaemia (Chattopadhyay et al. 1997b ) (see Table 1 ). The CaR has been localised to cells of the central nervous system (Rogers et al. 1997) , lens cells (Chattopadhyay et al. 1997a) , the intestine (Gama et al. 1997 , Ray et al. 1997 , Chattopadhyay et al. 1998 ) and the pancreas (Silva et al. 1994 , Wang et al. 1995 , Kato et al. 1997 ). The precise function of the receptor in these diverse tissues is unclear.
Gastrin secreting G-cells of the human antrum exhibit concentration-dependent, sustained and reversible Ca 2+ -induced changes in free cytosolic [Ca 2+ ] i and gastrin (Ray et al. 1997) . However, the Ca 2+ concentration required to activate these effects maximally is substantially higher than those required to activate the receptor in the parathyroid (3·6 mM compared with 1·1-1·3 mM). This decreased affinity of the receptor to its endogenous agonists in the antrum of the stomach is consistent with the concentrations of Ca 2+ normally present at this site. The affinity mirrors that observed in osteoclasts which, due to their role in bone resorption, are subject to chronically high concentrations of ionised Ca 2+ (Zaidi et al. 1993 ). However, it should be noted that, although the cationsensing mechanism present in osteoclasts is functionally similar to the CaR, it is distinct from the CaR at the molecular level (Quarles et al. 1997) . Although several studies have suggested that gastrin may be involved in the control of systemic Ca 2+ concentrations (Persson et al. 1989 , Hakanson et al. 1990 , it is more likely that the CaR modulates signalling events elicited by other receptor agonists (Squires et al. 1999) . Interestingly, hypercalcaemia in dogs has no effect on gastrin release (Reeder et al. 1970) and, in both dog and rat, hypercalcaemia results in decreased acid secretion (Barreras 1973) . Humans, monkeys, cats and ferrets, however, all show elevated gastrin secretion in response to raised extracellular Ca 2+ (Barreras & Donaldson 1967) . This may reflect species differences in the tissue-specific expression of the CaR (Wada et al. 1999) .
CaR in insulin-secreting -cells
The primary regulator of insulin release is a change in the plasma glucose concentration. Metabolism of glucose within the -cell alters the ATP/ADP ratio and closes ATP-dependent K + channels, which depolarises the cell membrane and opens VGCCs, elevating [ several studies have observed that Ca 2+ -induced increases in insulin secretion are transitory (Devis et al. 1975 , Nilsson et al. 1987 , whilst others have reported an actual decrease in secretion in response to elevated extracellular Ca 2+ under basal (Hellman 1975) and glucose-stimulated conditions (Hales & Milner 1968 , reviewed in Wollheim & Sharp 1981 . The recent localisation of the CaR on rodent (Rasschaert et al. 1998 ) and human pancreatic -cells (Squires et al. 2000) may help to explain these counter-intuitive data. Extracellular Ca 2+ is essential for glucose-induced insulin secretion (Hellman 1975) , and increasing extracellular Ca 2+ from 1·3 to 5 mM increases insulin secretion from human pancreatic islets (Squires et al. 2000) . However, this increase is transient, with the predominant effect being a sustained, reversible inhibition of both basal and glucose-induced insulin secretion. This Ca 2+ -induced inhibition of secretion is reminiscent of that observed in the PTH-secreting cells; however, changes in [Ca 2+ ] i were transient and cAMP content increased, suggesting that the PLC/InsP 3 and the adenylate cyclase/ cAMP pathways are not responsible for the prolonged inhibitory component of the response. An alternative, unidentified, pertussis toxin-sensitive G-protein-coupled mechanism, distal to the initial activation of the receptor (Sharp 1996) , may mediate the observed inhibition of insulin secretion by elevated extracellular Ca 2+ , in spite of associated increases in [Ca 2+ ] i .
Conclusion
The preceding commentary demonstrates the functional variability of the extracellular CaR beyond the control of systemic Ca 2+ homeostasis. Changes in extracellular Ca 2+ no longer merely represent a passive shift in the concentration gradient, by which the extent and duration of the response to other Ca 2+ -dependent receptor-mediated agonists are modulated. Extracellular Ca 2+ is itself an endogenous first messenger which can alter endocrine cell function. Interestingly, the same receptor appears able to stimulate and inhibit secretion in different cell types. Considering that the majority of studies on cell lines or isolated primary cellular material culture cells at 1·8 mM basal Ca 2+ , a concentration known to stimulate the CaR, the presence of the receptor on systems not directly involved in the maintenance of normocalcaemia has important repercussions. Clinically, the recent use of agents that mimic or potentiate the effects of extracellular Ca 2+ on the CaR (calcimimetics) (Silverberg et al. 1997 , Antonsen et al. 1998 
